Recombinant PRLR (Rolinsatamab Biosimilar) antibody
This Humanized Chimeric antibody specifically detects PRLR (Rolinsatamab Biosimilar) in ELISA and WB. It exhibits reactivity toward Human.
Catalog No. ABIN7538078
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant PRLR (Rolinsatamab Biosimilar) antibody (ABIN7538078)
Target
PRLR (Rolinsatamab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This PRLR (Rolinsatamab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Rolinsatamab Biosimilar - Anti-PRLR mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- PRLR (Rolinsatamab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Rolinsatamab is a potent dual IL-4 and IL-13 inhibitor as a fully humanized bispecific monoclonal antibody. Rolinsatamab chimeric antigen receptor sequence T cell. Rolinsatamab can be used in research of immune disease.
-
CAS-No
- 2095467-30-2
Target
-
You are here:
